Jay A. van Gerpen

4.9k total citations
67 papers, 2.2k citations indexed

About

Jay A. van Gerpen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jay A. van Gerpen has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 12 papers in Molecular Biology. Recurrent topics in Jay A. van Gerpen's work include Parkinson's Disease Mechanisms and Treatments (34 papers), Neurological disorders and treatments (25 papers) and Genetic Neurodegenerative Diseases (13 papers). Jay A. van Gerpen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (34 papers), Neurological disorders and treatments (25 papers) and Genetic Neurodegenerative Diseases (13 papers). Jay A. van Gerpen collaborates with scholars based in United States, Japan and Poland. Jay A. van Gerpen's co-authors include Zbigniew K. Wszołek, Dennis W. Dickson, Ryan J. Uitti, J. Eric Ahlskog, Shunsuke Koga, James H. Bower, William P. Cheshire, Neeraj Kumar, Keith A. Josephs and Neill R. Graff‐Radford and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jay A. van Gerpen

67 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay A. van Gerpen United States 26 1.6k 568 558 438 326 67 2.2k
Vincenzo Provitera Italy 26 1.1k 0.7× 626 1.1× 675 1.2× 190 0.4× 200 0.6× 78 2.2k
Anna De Rosa Italy 28 1.0k 0.7× 406 0.7× 249 0.4× 191 0.4× 388 1.2× 102 2.2k
Shinsuke Fujioka Japan 23 991 0.6× 387 0.7× 353 0.6× 318 0.7× 362 1.1× 113 1.6k
Ravi Yadav India 23 1.5k 1.0× 558 1.0× 193 0.3× 197 0.4× 267 0.8× 262 2.2k
Gregor Kuhlenbäumer Germany 29 1.1k 0.7× 469 0.8× 254 0.5× 231 0.5× 669 2.1× 106 2.4k
Antonio Emanuele Elia Italy 24 1.7k 1.1× 658 1.2× 295 0.5× 338 0.8× 398 1.2× 63 2.2k
Elmar H. Pinkhardt Germany 27 1.3k 0.8× 283 0.5× 251 0.4× 252 0.6× 221 0.7× 65 2.0k
Soniza Vieira Alves‐Leon Brazil 23 318 0.2× 366 0.6× 329 0.6× 483 1.1× 463 1.4× 94 2.1k
Tomohiko Mizutani Japan 22 761 0.5× 247 0.4× 272 0.5× 230 0.5× 405 1.2× 87 1.7k
Hayrettin Tumani Germany 21 626 0.4× 163 0.3× 424 0.8× 257 0.6× 386 1.2× 42 1.6k

Countries citing papers authored by Jay A. van Gerpen

Since Specialization
Citations

This map shows the geographic impact of Jay A. van Gerpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. van Gerpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. van Gerpen more than expected).

Fields of papers citing papers by Jay A. van Gerpen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. van Gerpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. van Gerpen. The network helps show where Jay A. van Gerpen may publish in the future.

Co-authorship network of co-authors of Jay A. van Gerpen

This figure shows the co-authorship network connecting the top 25 collaborators of Jay A. van Gerpen. A scholar is included among the top collaborators of Jay A. van Gerpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay A. van Gerpen. Jay A. van Gerpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koga, Shunsuke, William P. Cheshire, Philip W. Tipton, et al.. (2021). Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank. Parkinsonism & Related Disorders. 89. 155–161. 14 indexed citations
2.
Deutschländer, Angela, Takuya Konno, Alexandra I. Soto‐Beasley, et al.. (2020). Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease. Annals of Clinical and Translational Neurology. 7(9). 1557–1563. 6 indexed citations
3.
Wernick, Anna I., Audrey Strongosky, Alexandra I. Soto‐Beasley, et al.. (2020). Spinocerebellar ataxia type 6 family with phenotypic overlap with Multiple System Atrophy. Neurologia i Neurochirurgia Polska. 54(4). 350–355. 5 indexed citations
4.
Tipton, Philip W., et al.. (2019). Vocal Fold “Paralysis”: An Early Sign in Multiple System Atrophy. Journal of Voice. 34(6). 940–944. 4 indexed citations
5.
Kasanuki, Koji, Tanis J. Ferman, Melissa E. Murray, et al.. (2018). Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert. Parkinsonism & Related Disorders. 50. 99–103. 22 indexed citations
6.
Koga, Shunsuke, Naomi Kouri, Ronald L. Walton, et al.. (2018). Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathologica. 136(3). 389–404. 54 indexed citations
8.
Gerpen, Jay A. van, et al.. (2017). Different orthostatic hyperkinesias go “Thump”. Clinical Neurophysiology Practice. 2. 144–146. 1 indexed citations
9.
Blackburn, Patrick R., Michael T. Zimmermann, Jennifer Gass, et al.. (2016). A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics. BMC Medical Genetics. 17(1). 93–93. 10 indexed citations
10.
Hassan, Anhar, Michael G. Heckman, J. Eric Ahlskog, et al.. (2015). Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism & Related Disorders. 22. 102–105. 17 indexed citations
11.
Shannon, Barbara, Alexandra I. Soto‐Ortolaza, Sruti Rayaprolu, et al.. (2014). Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease. Neurobiology of Aging. 35(8). 1958.e1–1958.e2. 20 indexed citations
12.
Fujioka, Shinsuke, Mónica Sánchez-Contreras, Audrey Strongosky, et al.. (2014). Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism & Related Disorders. 21(2). 101–105. 32 indexed citations
13.
Gerpen, Jay A. van. (2014). A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus. Parkinsonism & Related Disorders. 20(8). 889–893. 22 indexed citations
14.
Labbé, Catherine, Alexandra I. Soto‐Ortolaza, Sruti Rayaprolu, et al.. (2013). Investigating the role of FUS exonic variants in Essential Tremor. Parkinsonism & Related Disorders. 19(8). 755–757. 25 indexed citations
15.
Gerpen, Jay A. van, et al.. (2012). Lifting the “FOG” With Laser Generated Visual-Cueing. The Neurologist. 18(5). 298–301. 7 indexed citations
16.
LeDoux, Mark S., Jianfeng Xiao, Monika Rudzińska, et al.. (2012). Genotype–phenotype correlations in THAP1 dystonia: Molecular foundations and description of new cases. Parkinsonism & Related Disorders. 18(5). 414–425. 55 indexed citations
17.
Gerpen, Jay A. van, Neeraj Kumar, James H. Bower, Stephen D. Weigand, & J. Eric Ahlskog. (2006). Levodopa-Associated Dyskinesia Risk Among Parkinson Disease Patients in Olmsted County, Minnesota, 1976-1990. Archives of Neurology. 63(2). 205–205. 108 indexed citations
18.
Gerpen, Jay A. van, et al.. (2005). Tick Paralysis. Mayo Clinic Proceedings. 80(7). 938–938. 2 indexed citations
19.
Elbaz, Alexis, Brett J. Peterson, Ping Yang, et al.. (2002). Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study. Epidemiology. 13(2). 157–164. 87 indexed citations
20.
Gerpen, Jay A. van. (2002). Drug-Induced Parkinsonism. The Neurologist. 8(6). 363–370. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026